Molecular mechanisms of exercise-induced cardiovascular adaptations. Influence of epigenetics, mechanotransduction and free radicals;Molekulare mechanismen der herz- Und gefäßanpassung durch sport: Einfluss von epigenetik, mechanotrans-duktion und freien radikalen

Herz

Volumn 37, Issue 5, 2012, Pages 508-517

  Bloch, W ^a   Suhr, F ^a   Zimmer, P ^a  

^a Institut fur Kreislaufforschung und Sportmedizin   (Germany)

Author keywords

Antioxidative capacity; Extracellular matrix; Functional genome; Nucleosomes; Oxidative stress; Signal transduction

Indexed keywords

FREE RADICAL;

ADAPTATION; ANTIOXIDANT ACTIVITY; ARTICLE; CELL STRUCTURE; EPIGENETICS; EXERCISE; EXERCISE INDUCED CARDIOVACULAR ADAPTATION; EXTRACELLULAR MATRIX; GENETIC REGULATION; GENOME; HUMAN; MECHANICAL STIMULATION; MECHANOTRANSDUCTION; OXIDATIVE STRESS; PHYSICAL ACTIVITY; SIGNAL TRANSDUCTION;

ADAPTATION, PHYSIOLOGICAL; BLOOD VESSELS; CARDIOVASCULAR PHYSIOLOGICAL PHENOMENA; EPIGENESIS, GENETIC; EXERCISE; FREE RADICALS; HEART; HUMANS; MECHANOTRANSDUCTION, CELLULAR;

EID: 84866550513     PISSN: 03409937     EISSN: 16156692     Source Type: Journal    
DOI: 10.1007/s00059-012-3637-6     Document Type: Article

References (67)

1. Comporti M (1989) Three models of free radical-induced cell injury. Chem Biol Interact 72:1-56.
2. Doerries C, Grote K, Hilfiker-Kleiner D et al (2007) Critical role of the NAD(P)H oxidase subunit p47phox for left ventricular remodeling/dysfunction and survival after myocardial infarction. Circ Res 100:894-903.
3. Duranteau J, Chandel NS, Kulisz A et al (1998) Intracellular signaling by reactive oxygen species during hypoxia in cardiomyocytes. J Biol Chem 273:11619-11624.
4. Kojda G, Hambrecht R (2005) Molecular mechanisms of vascular adaptations to exercise. Physical activity as an effective antioxidant therapy? Cardiovasc Res 67:187-197.
5. Therade-Matharan S, Laemmel E, Carpentier S et al (2005) Reactive oxygen species production by mitochondria in endothelial cells exposed to reoxygenation after hypoxia and glucose depletion is mediated by ceramide. Am J Physiol Regul Integr Comp Physiol 289:R1756-R1762.
6. Manea A, Constantinescu E, Popov D, Raicu M (2004) Changes in oxidative balance in rat pericy-tes exposed to diabetic conditions. J Cell Mol Med 8:117-126.
7. Bae YS, Lee JH, Choi SH et al (2009) Macrophages generate reactive oxygen species in response to minimally oxidized low-density lipoprotein: toll-like receptor 4- and spleen tyrosine kinase-de-pendent activation of NADPH oxidase 2. Circ Res 104:210-218.
8. Gupta M, Singal PK (1989) Higher antioxidative capacity during a chronic stable heart hypertrophy. Circ Res 64:398-406.
9. Gao L, Wang W, Liu D, Zucker IH (2007) Exercise training normalizes sympathetic outflow by cen-tral antioxidant mechanisms in rabbits with pacing-induced chronic heart failure. Circulation 115:3095-3102.
10. Richters L, Lange N, Renner R et al (2011) Exercise-induced adaptations of cardiac redox homeostasis and remodeling in heterozygous SOD2-knockout mice. J Appl Physiol 111:1431-1440.
11. Stephens NG, Parsons A, Schofield PM et al (1996) Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet 347:781-786.
12. Ohara Y, Peterson TE, Harrison DG (1993) Hypercholesterolemia increases endothelial superoxide anion production. J Clin Invest 91:2546-2551.
13. Morrell CN (2008) Reactive oxygen species: finding the right balance. Circ Res 103:571-572.
14. Gozin A, Franzini E, Andrieu V et al (1998) Reactive oxygen species activate focal adhesion kinase, paxillin and p130cas tyrosine phosphorylation in endothelial cells. Free Radic Biol Med 25:1021-1032.
15. Szostak J, Laurant P (2011) The forgotten face of regular physical exercise: a 'natural' anti-atherogenic activity. Clin Sci (Lond) 121:91-106.
16. Wang JS, Lee T, Chow SE (2006) Role of exercise intensities in oxidized low-density lipoprotein-mediated redox status of monocyte in men. J Appl Physiol 101:740-744.
17. Brown MD, Hudlicka O (2003) Modulation of physiological angiogenesis in skeletal muscle by me-chanical forces: involvement of VEGF and metalloproteinases. Angiogenesis 6:1-14.
18. Waters RE, Rotevatn S, Li P et al (2004) Voluntary running induces fiber type-specific angiogenesis in mouse skeletal muscle. Am J Physiol Cell Physiol 287:C1342-C1348.
19. Suhr F, Brixius K de MM, Bolck B et al (2007) Effects of short-term vibration and hypoxia during high-intensity cycling exercise on circulating levels of angiogenic regulators in humans. J Appl Physiol 103:474-483.
20. Shang F, Wang J, Liu X et al (2012) Involvement of reactive oxygen species and JNK in increased expression of MCP-1 and infiltration of inflammatory cells in pressure-overloaded rat hearts. Mol Med Report 5(6):1491-1496.
21. Martinez-Lemus LA, Zhao G, Galinanes EL, Boone M (2011) Inward remodeling of resistance arteries requires reactive oxygen species-dependent activation of matrix metalloproteinases. Am J Physiol Heart Circ Physiol 300:H2005-H2015.
22. Biswas S, Gupta MK, Chattopadhyay D, Mukhopadhyay CK (2007) Insulin-induced activation of hypoxia-inducible factor-1 requires generation of reactive oxygen species by NADPH oxidase. Am J Physiol Heart Circ Physiol 292:H758-H766.
23. Wang Y, Zang QS, Liu Z et al (2011) Regulation of VEGF-induced endothelial cell migration by mi-tochondrial reactive oxygen species. Am J Physiol Cell Physiol 301:C695-C704.
24. Kliment CR, Oury TD (2010) Oxidative stress, extracellular matrix targets, and idiopathic pulmonary fibrosis. Free Radic Biol Med 49:707-717.
25. Giedt RJ, Yang C, Zweier JL et al (2012) Mitochondrial fission in endothelial cells after simulated ischemia/reperfusion: role of nitric oxide and reactive oxygen species. Free Radic Biol Med 52:348-356.
26. Prior BM, Yang HT, Terjung RL (2004) What makes vessels grow with exercise training? J Appl Physiol 97:1119-1128.
27. Green DJ, Maiorana A, O'Driscoll G, Taylor R (2004) Effect of exercise training on endothelium-derived nitric oxide function in humans. J Physiol 561:1-25.
28. DeBosch B, Treskov I, Lupu TS et al (2006) Akt1 is required for physiological cardiac growth. Circulation 113:2097-2104.
29. McMullen JR, Shioi T, Zhang L et al (2003) Phosphoinositide 3-kinase(p110alpha) plays a critical role for the induction of physiological, but not pathological, cardiac hypertrophy. Proc Natl Acad Sci U S A 100:12355-12360.
30. Hynes RO (2002) Integrins: bidirectional, allosteric signaling machines. Cell 110:673-687.
31. Seth M, Zhang ZS, Mao L et al (2009) TRPC1 channels are critical for hypertrophic signaling in the heart. Circ Res 105:1023-1030.
32. Sturek M (2011) Ca2+ regulatory mechanisms of exercise protection against coronary artery disease in metabolic syndrome and diabetes. J Appl Physiol 111:573-586.
33. Sagara S, Osanai T, Itoh T et al (2012) Overexpression of coupling factor 6 attenuates exercise-in-duced physiological cardiac hypertrophy by inhibiting PI3K/Akt signaling in mice. J Hypertens 30:778-786.
34. Knoll R, Linke WA, Zou P et al (2011) Telethonin deficiency is associated with maladaptation to biomechanical stress in the mammalian heart. Circ Res 109:758-769.
35. Suhr F, Brixius K, Bloch W (2009) Angiogenic and vascular modulation by extracellular matrix clea-vage products. Curr Pharm Des 15:389-410.
36. Schmidt A, Wenzel D, Ferring I et al (2004) Influence of endostatin on embryonic vasculo- and an-giogenesis. Dev Dyn 230:468-480.
37. Bloch W, Huggel K, Sasaki T et al (2000) The angiogenesis inhibitor endostatin impairs blood ves-sel maturation during wound healing. FASEB J 14:2373-2376.
38. Wenzel D, Schmidt A, Reimann K et al (2006) Endostatin, the proteolytic fragment of collagen XVIII, induces vasorelaxation. Circ Res 98:1203-1211.
39. Lauten A, Majos E, Muhlich A et al (2009) Ischemia-reperfusion injury activates early extracellular matrix processing and expression of endostatin in the heart with differential effects of temperature. Basic Res Cardiol 104:559-569.
40. Suhr F, Rosenwick C, Vassiliadis A et al (2010) Regulation of extracellular matrix compounds involved in angiogenic processes in short- and long-track elite runners. Scand J Med Sci Sports 20:441-448.
41. Brixius K, Schoenberger S, Ladage D et al (2008) Long-term endurance exercise decreases antian-giogenic endostatin signalling in overweight men aged 50-60 years. Br J Sports Med 42:126-129.
42. Wu C (1997) Chromatin remodeling and the control of gene expression. J Biol Chem 272:28171-28174.
43. Jenuwein T, Allis CD (2001) Translating the histone code. Science 293:1074-1080.
44. Pons D, Vries FR de, Elsen PJ van den et al (2009) Epigenetic histone acetylation modifiers in vascular remodelling: new targets for therapy in cardiovascular disease. Eur Heart J 30:266-277.
45. Marenberg ME, Risch N, Berkman LF et al (1994) Genetic susceptibility to death from coronary heart disease in a study of twins. N Engl J Med 330:1041-1046.
46. Nakajima K, Takeoka M, Mori M et al (2010) Exercise effects on methylation of ASC gene. Int J Sports Med 31:671-675.
47. Barnes PJ, Karin M (1997) Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 336:1066-1071.
48. Ito K, Hanazawa T, Tomita K et al (2004) Oxidative stress reduces histone deacetylase 2 activity and enhances IL-8 gene expression: role of tyrosine nitration. Biochem Biophys Res Commun 315:240-245.
49. Ito K, Barnes PJ, Adcock IM (2000) Glucocorticoid receptor recruitment of histone deacetylase 2 inhibits interleukin-1beta-induced histone H4 acetylation on lysines 8 and 12. Mol Cell Biol 20:6891-6903.
50. Ito K, Jazrawi E, Cosio B et al (2001) p65-activated histone acetyltransferase activity is repressed by glucocorticoids: mifepristone fails to recruit HDAC2 to the p65-HAT complex. J Biol Chem 276:30208-30215.
51. Miao F, Gonzalo IG, Lanting L, Natarajan R (2004) In vivo chromatin remodeling events leading to inflammatory gene transcription under diabetic conditions. J Biol Chem 279:18091-18097.
52. Emanuele E, Falcone C, D'Angelo A et al (2006) Association of plasma eotaxin levels with the presence and extent of angiographic coronary artery disease. Atherosclerosis 186:140-145.
53. Nie M, Knox AJ, Pang L (2005) beta2-Adrenoceptor agonists, like glucocorticoids, repress eotaxin gene transcription by selective inhibition of histone H4 acetylation. J Immunol 175:478-486.
54. Shindo J, Ishibashi T, Yokoyama K et al (1999) Granulocyte-macrophage colony-stimulating factor prevents the progression of atherosclerosis via changes in the cellular and extracellular composition of atherosclerotic lesions in watanabe heritable hyperlipidemic rabbits. Circulation 99:2150-2156.
55. McDonald OG, Owens GK (2007) Programming smooth muscle plasticity with chromatin dyna-mics. Circ Res 100:1428-1441.
56. McDonald OG, Wamhoff BR, Hoofnagle MH, Owens GK (2006) Control of SRF binding to CArG box chromatin regulates smooth muscle gene expression in vivo. J Clin Invest 116:36-48.
57. Kawahara K, Kawabata H, Aratani S, Nakajima T (2003) Hyper nuclear acetylation (HNA) in prolife-ration, differentiation and apoptosis. Ageing Res Rev 2:287-297.
58. Okamoto H, Fujioka Y, Takahashi A et al (2006) Trichostatin A, an inhibitor of histone deacetylase, inhibits smooth muscle cell proliferation via induction of p21(WAF1). J Atheroscler Thromb 13:183-191.
59. Galis ZS, Sukhova GK, Lark MW, Libby P (1994) Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest 94:2493-2503.
60. Rodriguez-Salvador J, Armas-Pineda C, Perezpena-Diazconti M et al (2005) Effect of sodium butyrate on pro-matrix metalloproteinase-9 and -2 differential secretion in pediatric tumors and cell lines. J Exp Clin Cancer Res 24:463-473.
61. Ailenberg M, Silverman M (2002) Trichostatin A-histone deacetylase inhibitor with clinical thera-peutic potential-is also a selective and potent inhibitor of gelatinase A expression. Biochem Biophys Res Commun 298:110-115.
62. Liu LT, Chang HC, Chiang LC, Hung WC (2003) Histone deacetylase inhibitor up-regulates RECK to inhibit MMP-2 activation and cancer cell invasion. Cancer Res 63:3069-3072.
63. Young DA, Lakey RL, Pennington CJ et al (2005) Histone deacetylase inhibitors modulate metall-oproteinase gene expression in chondrocytes and block cartilage resorption. Arthritis Res Ther 7:R503-R512.
64. Puddu GM, Cravero E, Arnone G et al (2005) Molecular aspects of atherogenesis: new insights and unsolved questions. J Biomed Sci 12:839-853.
65. Cao D, Wang Z, Zhang CL et al (2005) Modulation of smooth muscle gene expression by associati-on of histone acetyltransferases and deacetylases with myocardin. Mol Cell Biol 25:364-376.
66. Sun Z, Singh N, Mullican SE et al (2011) Diet-induced lethality due to deletion of the Hdac3 gene in heart and skeletal muscle. J Biol Chem 286:33301-33309.
67. Montgomery RL, Potthoff MJ, Haberland M et al (2008) Maintenance of cardiac energy metabo-lism by histone deacetylase 3 in mice. J Clin Invest 118:3588-3597.